Russell Investments Group
BIOR

Russell Investments Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Russell Investments Group’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4
Closed -$9K – 3284
2020
Q2 		$9K Buy
+4
New +$10.9K ﹤0.01% 3079

Other funds holding BIOR

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Russell Investments Group's BIOR Position: Q3 2020 in Review

Russell Investments Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q3 2020, closing a stake of 4 shares — an estimated $9K sold.

Russell Investments Group first reported a position in BIOR in Q2 2020 and held it in 1 quarter. The position peaked at $9K in Q2 2020. 39 funds tracked by Wall St. Rank hold BIOR as of Q3 2020.

  • Russell Investments Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Russell Investments Group sold 4 Biora Therapeutics, Inc. Common Stock shares in Q3 2020, an estimated $9K.
  • Russell Investments Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Russell Investments Group's Biora Therapeutics, Inc. Common Stock position peaked at $9K in Q2 2020.
  • 39 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q3 2020.

Based on Russell Investments Group's 13F filing for Q3 2020, filed 9 Nov 2020.